Serum soluble Fas levels and incidence of biliary tract cancer in a nested case-control study.
High serum sFas may be related to future risk of extrahepatic biliary tract cancer in a prospective case-control study nested in the Japan Collaborative Cohort study, highlighting the need for additional studies of this biomarker in large prospective cohorts and through integrated analysis involving other cohorts.